We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

MabCure Launches Clinical Trial to Diagnose Ovarian Cancer

News   Jan 07, 2010

 
MabCure Launches Clinical Trial to Diagnose Ovarian Cancer
 
 
Advertisement
 

RELATED ARTICLES

Evidence for a DNA Methylation Signature of ASD in Cord Blood

News

A new study led by UC Davis MIND Institute researchers found a distinct DNA methylation signature in the cord blood of newborns who were eventually diagnosed with autism spectrum disorder (ASD). This signature mark spanned DNA regions and genes linked to early fetal neurodevelopment. The findings may hold clues for early diagnosis and intervention.

READ MORE

FDA Approves Remdesivir for COVID-19

News

The US Food and Drug Administration has approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients (≥ 12 years of age and weighing at least 40 kg) for the treatment of COVID-19 requiring hospitalization.

READ MORE

How Do Our Immune Systems Develop in the First Days of Life?

News

In the womb, a human fetus has limited contact with pathogens. However, once born, babies face a myriad of germs completely new to their bodies. Their immune system must rapidly develop to ensure early protection from infection. But what is exactly the dynamic of the immune system development in the first days of life?

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE